Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F
Open Access
- 29 December 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (3), 1046-1051
- https://doi.org/10.1073/pnas.1011477108
Abstract
Deregulation of cap-dependent translation is associated with cancer initiation and progression. The rate-limiting step of protein synthesis is the loading of ribosomes onto mRNA templates stimulated by the heterotrimeric complex, eukaryotic initiation factor (eIF)4F. This step represents an attractive target for anticancer drug discovery because it resides at the nexus of the TOR signaling pathway. We have undertaken an ultra-high-throughput screen to identify inhibitors that prevent assembly of the eIF4F complex. One of the identified compounds blocks interaction between two subunits of eIF4F. As a consequence, cap-dependent translation is inhibited. This compound can reverse tumor chemoresistance in a genetically engineered lymphoma mouse model by sensitizing cells to the proapoptotic action of DNA damage. Molecular modeling experiments provide insight into the mechanism of action of this small molecule inhibitor. Our experiments validate targeting the eIF4F complex as a strategy for cancer therapy to modulate chemosensitivity.Keywords
This publication has 29 references indexed in Scilit:
- Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, SilvestrolPLOS ONE, 2009
- Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniquesBioinformatics, 2009
- mTORC1 promotes survival through translational control of Mcl-1Proceedings of the National Academy of Sciences, 2008
- c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and TranslationCancer Research, 2008
- Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma modelJCI Insight, 2008
- Dissecting eIF4E action in tumorigenesisGenes & Development, 2007
- Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicityJCI Insight, 2007
- Initiation of Protein Synthesis by Hepatitis C Virus Is Refractory to Reduced eIF2 · GTP · Met-tRNAiMetTernary Complex AvailabilityMolecular Biology of the Cell, 2006
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- The requirement for eukaryotic initiation factor 4A (eIF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structureRNA, 2001